<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chemoprophylaxis regimens for protection against meningococcal disease&lt;sup&gt;[1-3]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chemoprophylaxis regimens for protection against meningococcal disease<sup>[1-3]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Chemoprophylaxis regimens for protection against meningococcal disease<sup>[1-3]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Age group</td> <td class="subtitle1">Dose</td> <td class="subtitle1">Duration and route of administration</td> </tr> <tr class="highlight_lght_gray_text"> <td colspan="4"><strong class="heading">Preferred regimens</strong></td> </tr> <tr> <td class="indent1" rowspan="3">Rifampin*</td> <td>Infants age &lt;1 month</td> <td>5 mg/kg/<strong>dose</strong> every 12 hours</td> <td>2 days (4 doses) of oral therapy</td> </tr> <tr> <td>Infants and children age ≥1 month</td> <td>10 mg/kg/<strong>dose</strong> (maximum: 600 mg) every 12 hours</td> <td>2 days (4 doses) of oral therapy</td> </tr> <tr> <td>Adults</td> <td>600 mg every 12 hours</td> <td>2 days (4 doses) of oral therapy</td> </tr> <tr> <td class="indent1" rowspan="2">Ciprofloxacin<sup>¶</sup></td> <td>Infants and children age ≥1 month</td> <td>20 mg/kg (maximum 500 mg)</td> <td>Single oral dose</td> </tr> <tr> <td>Adults</td> <td>500 mg</td> <td>Single oral dose</td> </tr> <tr> <td class="indent1" rowspan="2">Ceftriaxone</td> <td>Children age &lt;15 years</td> <td>125 mg</td> <td>Single IM dose</td> </tr> <tr> <td>Adults and adolescents age ≥15 years</td> <td>250 mg</td> <td>Single IM dose</td> </tr> <tr class="highlight_lght_gray_text"> <td colspan="4"><strong class="heading">Alternative regimen</strong> (eg, if rifampin or ceftriaxone cannot be used in the setting of ciprofloxacin-resistant <em>Neisseria meningitidis</em> exposure)</td> </tr> <tr> <td class="indent1" rowspan="2">Azithromycin<sup>Δ</sup></td> <td>Infants and children</td> <td>10 mg/kg (maximum 500 mg)</td> <td>Single oral dose</td> </tr> <tr> <td>Adults</td> <td>500 mg</td> <td>Single oral dose</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>IM: intramuscular.</p>
<p>* Rifampin is not recommended for pregnant women because the drug is teratogenic in laboratory animals. Because the reliability of oral contraceptives might be affected by rifampin therapy, consideration should be given to using alternative contraceptive measures while rifampin is being administered. For additional information on drug interactions, refer to the Lexicomp drug interaction program within UpToDate.</p>
<p>¶ Ciprofloxacin should not be used if fluoroquinolone-resistant strains of <em>N. meningitidis</em> have been identified in the community. In addition, ciprofloxacin is not recommended for pregnant women. Although systemic fluoroquinolones are not routinely used as a first-line agent in children less than 18 years of age, it is reasonable to use a single dose of ciprofloxacin for chemoprophylaxis for meningococcal disease.</p>
Δ Although azithromycin has activity against meningococcus, it has not been well studied for this indication.</div><div class="graphic_reference">References:
<ol>
<li>Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1.</li>
<li>American Academy of Pediatrics. Meningococcal infections. In: Red Book: 2021–2024 Report of the Committee on Infectious Diseases, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics 2021.</li>
<li>McNamara LA, Blain A. Chapter 8: Meningococcal Disease. In: Manual for the Surveillance of Vaccine-Preventable Diseases, Roush SW, Baldy LM, Hall MAK (Eds), Centers for Disease Control and Prevention. Available at: <a href="https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html" target="_blank">https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html</a> (Accessed on August 3, 2022).</li>
</ol></div><div id="graphicVersion">Graphic 51944 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
